- Apr 2017
-
www.cimzia.com www.cimzia.com
-
are being treated for an infection, or get a lot of infections or have infections that keep coming back have diabetes, HIV, or a weak immune system. People with these conditions have a higher chance for infections. have tuberculosis (TB), or have been in close contact with someone with TB were born in, lived in, or traveled to countries where there is more risk of getting TB. Ask your healthcare provider if you are not sure. live or have lived in certain parts of the country (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections (histoplasmosis, coccidioidomycosis, blastomycosis). These infections may develop or become more severe if you take CIMZIA. If you do not know if you have lived in an area where histoplasmosis, coccidioidomycosis, or blastomycosis is common, ask your healthcare provider. have or have had hepatitis B
-
-
www.google.com www.google.com
-
as determined by polyacrylamide gel electrophoresis, said cytotoxin being obtainable from stimulated human monocytes, said cytotoxin being further characterized by exhibiting a cytotoxic effect on cycloheximide-sensitized SV-80 cells and by being obtainable in a state of enhanced purity by adsorption of the cytotoxin from an impure preparation onto controlled pore glass beads, and subsequent desorption of the cytotoxin in a state of enhanced purity
-
A monoclonal antibody
The spec only refers to murine (mouse derived) monoclonal antibodies.
- Statement one
- Statement two
- Another statement
-
A monoclonal antibody
This is an annotation to "A momodsfgkjsdkjgkjlsd" in claim 5
-
- Mar 2017
-
hypothes.is hypothes.is
-
A monoclonal antibody
Patent specification only ever refers to murine (mouse-derived) monoclonal antibodies.
-
-
en.wikipedia.org en.wikipedia.org
-
It is a fragment of a monoclonal antibody
-
a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) and is manufactured by UCB
-
a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) and is manufactured by UCB
-
-
www.google.com www.google.com
-
molecular weight of about 17,500 as determined by polyacrylamide gel electrophoresis
-
a human cytotoxin having a molecular weight of about 17,500
-
monoclonal antibody which specifically binds a human cytotoxin
-
-
www.google.com www.google.com
-
9. The computing device of claim 1
And now I can add my own annotation. Hmm, okay now, how do I replicate what you did, and add a hyp.is back-link to the citing Apple v. Motorola case, pinpointing where this specific claim 9 is referenced?
Okay, I see the share button showed me "https://hyp.is/-JzDTg2KEee5a7P1hOD7OQ/casetext.com/case/apple-inc-v-motorola-inc-5" but why is my only option to "share" with "Only me"? Anyway, I'm starting to get a feel for how this would work.
I think I would want to be able to do is assign designations to each part of each patent claim. Here example, "instructions for processing the first command;" might be called 7479949.9.3 (because it's the 3rd element of claim 9). I would want to be able to each each element in its own row on the left side of a 2-column table, and use the right side to plop in information from other sources regarding infringement or prior art pertaining to the specific element in that row.
See illustrations in this article: https://www.linkedin.com/pulse/claim-charts-patent-litigation-brief-introduction-andrew-schulman
A client of mine is interested in automated processes for generating such charts, as well as for the task I mentioned yesterday of taking chunks from deposition transcripts and creating tables/charts around them. Sort of a combination of a wiki and a chart. Do you have an article you've written that I could pass on to them, where it would be only a short hop to what I've just described (if it makes any sense) from what you've written? I'd like to get you in touch with them soon.
-
-
-
9
See https://www.google.com/patents/US7479949 but I want to link specifically to claim 9 ("The computing device of claim 1, including: [] instructions for detecting one or more first finger contacts with the touch screen display while a web browser application is displayed on the touch screen display; ...")
-
-
www.google.com www.google.com
-
ATCC CRL 9459
-
ATCC CRL 9453
-
-
www.softwarelitigationconsulting.com www.softwarelitigationconsulting.com
-
Comparing two texts is often difficult enough; aligning, or showing lack of alignment between, text and non-text materials (or quasi-text such as computer software) is more so, or at least more problematic than the scant attention to claim charts would suggest.
This is a test.
-